172 related articles for article (PubMed ID: 37243682)
1. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
Prezioso G; Chiarelli F; Matricardi S
Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
[TBL] [Abstract][Full Text] [Related]
3. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
4. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
[TBL] [Abstract][Full Text] [Related]
5. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
[TBL] [Abstract][Full Text] [Related]
6. Vigabatrin - new data on indications and safety in paediatric epilepsy.
Golec W; Sołowiej E; Strzelecka J; Jurkiewicz E; Jóźwiak S
Neurol Neurochir Pol; 2021; 55(5):429-439. PubMed ID: 34541635
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
[TBL] [Abstract][Full Text] [Related]
8. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis].
Ando N; Fujimoto S; Ishikawa T; Kobayashi S; Hattori A; Ito T; Togari H
No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
Camposano SE; Major P; Halpern E; Thiele EA
Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin for tuberous sclerosis complex.
Curatolo P; Verdecchia M; Bombardieri R
Brain Dev; 2001 Nov; 23(7):649-53. PubMed ID: 11701271
[TBL] [Abstract][Full Text] [Related]
12. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
van der Poest Clement EA; Sahin M; Peters JM
J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
Hancock E; Osborne JP
J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
Yum MS; Lee EH; Ko TS
J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
Friedman D; Bogner M; Parker-Menzer K; Devinsky O
Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
17. Real-life data comparing the efficacy of vigabatrin and oral steroids given sequentially or combined for infantile epileptic spasms syndrome.
Dozieres-Puyravel B; Nasser H; Mauvais FX; De Saint Martin A; Perriard C; Di Meglio C; Cances C; Hachon-LE Camus C; Milh M; Auvin S
Eur J Paediatr Neurol; 2024 Jan; 48():61-66. PubMed ID: 38041897
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.
Chiron C; Dumas C; Jambaqué I; Mumford J; Dulac O
Epilepsy Res; 1997 Jan; 26(2):389-95. PubMed ID: 9095401
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin: 2008 update.
Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
[TBL] [Abstract][Full Text] [Related]
20. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
Iyer A; Appleton R
Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]